On Oct 7, Healthway Medical Corporation executive director and deputy CEO Abram Suhardiman acquired 30.5 million shares of the Catalist-listed company for a consideration of S$976,000. At 3.2 cents per share, this took his total interest in Healthway Medical Corporation from 0.19 per cent to 0.86 per cent.

 

This followed his acquisition of 8,452,900 shares on Sept 29, also at 3.2 cents per share.

 

He is responsible for overseeing the Group' s operations and corporate support functions including finance, legal, marketing, human resources, corporate communications and information technology divisions, and assisting the CEO in strategic planning and managing all aspects of the company and the group' s business.

 

Prior to joining Healthway, he served as vice-president at Nuvest Capital.

 

He has also worked at The Abraaj Group and Citibank where he was part of the investment team in South-east Asia.

 

As of the end of 2019, Healthway Medical Corporation owned, operated and managed 91 clinics and medical centres. These facilities are in most parts of Singapore, including many major private hospitals.

 

The company noted in early August that over the preceding few months it had taken the opportunity to accelerate its digitalisation journey both for internal processes and for its patients.

 

The company rolled out enhanced infrastructures for its backend systems to strengthen operational efficiency, as well as utilise teleconsultation platforms at its general practice and specialist clinics and signalled that it will continue to broaden and enhance these platforms to cater to the evolving needs of its patients in the future.